150 related articles for article (PubMed ID: 3958138)
1. Emergence of bactericidal and opsonizing antibody to Vibrio vulnificus following bacterial infection.
Musher DM; Hansen MV; Goree A; Gyorkey F; Chapman AJ; Baughn RE
J Clin Microbiol; 1986 Mar; 23(3):411-5. PubMed ID: 3958138
[TBL] [Abstract][Full Text] [Related]
2. Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans.
Johnson DE; Calia FM; Musher DM; Goree A
J Infect Dis; 1984 Sep; 150(3):413-8. PubMed ID: 6481186
[TBL] [Abstract][Full Text] [Related]
3. Vibrio vulnificus resists phagocytosis in the absence of serum opsonins.
Tamplin ML; Specter S; Rodrick GE; Friedman H
Infect Immun; 1985 Sep; 49(3):715-8. PubMed ID: 4030101
[TBL] [Abstract][Full Text] [Related]
4. Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.
Dahlberg-Lagergård T
Acta Pathol Microbiol Immunol Scand C; 1982 Aug; 90(4):209-16. PubMed ID: 6982592
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein.
Peterson PK; Schmeling D; Cleary PP; Wilkinson BJ; Kim Y; Quie PG
J Infect Dis; 1979 May; 139(5):575-85. PubMed ID: 374652
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum.
Rice PA; Vayo HE; Tam MR; Blake MS
J Exp Med; 1986 Nov; 164(5):1735-48. PubMed ID: 3095479
[TBL] [Abstract][Full Text] [Related]
7. Vibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection.
Wang MY; Liu XF; Xia J; Li Y; Geng JL; Hu CJ
Future Microbiol; 2017 Sep; 12():953-965. PubMed ID: 28816516
[TBL] [Abstract][Full Text] [Related]
8. Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species.
Tamplin ML; Specter S; Rodrick GE; Friedman H
Infect Immun; 1983 Dec; 42(3):1187-90. PubMed ID: 6642665
[TBL] [Abstract][Full Text] [Related]
9. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
Gnehm HE; Pelton SI; Gulati S; Rice PA
J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
[TBL] [Abstract][Full Text] [Related]
10. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies to Vibrio vulnificus biotype 3 lipopolysaccharide and susceptibility to disease caused by the homologous V. vulnificus biotype.
Bisharat N; Bialik A; Paz E; Amaro C; Cohen DI
Epidemiol Infect; 2011 Mar; 139(3):472-81. PubMed ID: 20492749
[TBL] [Abstract][Full Text] [Related]
12. A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis.
Agüero ME; Aron L; DeLuca AG; Timmis KN; Cabello FC
Infect Immun; 1984 Dec; 46(3):740-6. PubMed ID: 6389361
[TBL] [Abstract][Full Text] [Related]
13. Role of antibody and complement in opsonization of group B streptococci.
Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
[TBL] [Abstract][Full Text] [Related]
15. Antibodies that react with the capsular polysaccharide of Vibrio vulnificus are detectable in infected patients, and in persons without known exposure to the organism.
Fiore A; Hayat U; Wasserman SS; Wright A; Bush CA; Morris JG
Diagn Microbiol Infect Dis; 1996 Mar; 24(3):165-7. PubMed ID: 8724403
[TBL] [Abstract][Full Text] [Related]
16. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.
Kochi SK; Johnson RC
Infect Immun; 1988 Feb; 56(2):314-21. PubMed ID: 3276623
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
[TBL] [Abstract][Full Text] [Related]
18. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
19. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
Selander B; Käyhty H; Wedege E; Holmström E; Truedsson L; Söderström C; Sjöholm AG
J Clin Immunol; 2000 Mar; 20(2):138-49. PubMed ID: 10821465
[TBL] [Abstract][Full Text] [Related]
20. Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.
Rakita RM; Quan VC; Jacques-Palaz K; Singh KV; Arduino RC; Mee M; Murray BE
FEMS Immunol Med Microbiol; 2000 Aug; 28(4):291-9. PubMed ID: 10891652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
